Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-α

Teratology

Volumn 56, Issue 5, 1997, Pages 311-316

  Peters, Jeffrey M ^a   Taubeneck, Marie W ^b   Keen, Carl L ^b,c   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG VEHICLE; MESSENGER RNA; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; FEMALE; MOUSE; NONHUMAN; PLEIOTROPY; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; ZINC DEFICIENCY; ZINC METABOLISM;

ANIMALIA; RODENTIA;

EID: 0031441443     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9926(199711)56:5<311::aid-tera4>3.0.co;2-%23     Document Type: Article

References (31)

1. Amemiya, K., C.L. Keen, and L.S. Hurley (1986) 6-Mercaptopurine-induced alterations in mineral metabolism and teratogenesis in the rat. Teratology, 34:321-334.
2. 65Zn distribution in the pregnant rat. Teratology, 39:387-393.
3. Cariot, P., E. Barrat, L. Mejean, J.P. Pointel, P. Drouin and G. Debbry (1983) Fenofibrate and human liver: Lack of proliferation of peroxisomes. Arch. Toxicol., 53:151-163.
4. Clegg, M.S., C.L. Keen, B. Lonnerdal and L.S. Hurley (1981) Influence of ashing techniques on the analysis of trace elements in animal tissues. Biol. Trace. Element Res., 3:107-115.
5. Daston, G.P., G.J. Overmann, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers and C.L. Keen (1991) The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: Comparison of the effects of urethane and styrene in rats. Toxicol. Appl. Pharmacol., 110:450-63.
6. Daston, G.P., G.J. Overmann, D. Baines, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers and C.L. Keen (1994) Altered Zn status by alpha-hederin in the pregnant rat and its relationship to adverse developmental outcome. Reprod. Toxicol., 8:15-24.
7. De La Iglesia, F.A., J.E. Lewis, R.A. Buchanan, E.L. Marcus and G. McMahon (1982) Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis, 43:19-37.
8. Gottlicher, M., E. Widmark, Q. Li and J.A. Gustafsson (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A., 89:4653-7.
9. Issemann, I., R.A. Prince, J.D. Tugwood and S. Green (1993) The peroxisome proliferator-activated receptor:retinoid x receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol., 11:37-47.
10. Keen, C.L. (1996) Teratogenic effects of essential trace elements: Deficiencies and excesses. In: Toxicology of Metals. L.W. Chang, ed. Boca Raton: CRC, pp. 977-1001.
11. Keen, C.L., J.M. Peters and L.S. Hurley (1989) The effect of valproic acid on 65Zn distribution in the pregnant rat. J. Nutr., 119:607-11.
12. Kliewer, S.A., S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, C.S. Koble, P. Devchand, W. Wahli, T.M. Willson, J.M. Lenhard and J.M. Lehmann (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. U.S.A., 94:4318-23.
13. Lee, S.S., T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal and F.J. Gonzalez (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol., 75:3012-22.
14. Lehman-McKeeman, L.D., G.K. Andrews and C.D. Klaassen (1988) Mechanisms of regulation of rat hepatic metallothionein-I and metallothionein-II levels following administration of zinc. Toxicol. Appl. Pharmacol., 92:1-9.
15. Moody, D.E., J.K. Reddy, B.G. Lake, J.A. Popp and D.H. Reese (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium. Fundam. Appl. Toxicol., 16:233-48.
16. Motojima, K. (1993) Peroxisome proliferator-activated receptor (PPAR): Structure, mechanisms of activation and diverse functions. Cell Struct. Funct., 18:267-77.
17. Onosaka, S. and M.G. Cherian (1982) Comparison of metallothionein determination by polarographic and cadmium-saturation methods. Toxicol. Appl. Pharmacol., 63:270-4.
18. Parkhie, M.R., M. Webb and M.A. Norcross (1982) Dimethoxyethyl phthalate: Embryopathy, teratogenicity, fetal metabolism and the role of zinc in the rat. Environ. Health Perspect., 45:89-97.
19. Peters, J.M., Y.C. Zhou, P.A. Ram, S.S. Lee, F.J. Gonzalez and D.J. Waxman (1996) Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Mol. Pharmacol., 50:67-74.
20. Peters, J.M., R.C. Cattley and F.J. Gonzalez (1997) Role of PPAR-alpha in the mechanism of action of the non-genotoxic carcinogen and peroxisome proliferator Wy-14,643. Cancer. Res., in press.
21. Rao, M.S., S. Musunuri and J.K. Reddy (1992) Dehydroepiandrosterone-induced peroxisome proliferation in the rat liver. Pathobiology, 60:82-6.
22. Ren, B., A.P. Thelen, J.M. Peters, F.J. Gonzalez and D.B. Jump (1997) Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require PPARα. J. Biol. Chem., 272:26827-26832.
23. Shiota, K. and S. Mima (1985) Assessment of the teratogenicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in mice. Arch. Toxicol., 56:263-6.
24. Shiota, K. and H. Nishimura (1982) Teratogenicity of di(2-ethylhexyl)phthyalate (DEHP) and di-n-butyl phthalate (DBP) in mice. Environ. Health Perspect., 45:65-70.
25. Singh, A.R., W.H. Lawrence and J. Autian (1972) Teratogenicity of phthalate esters in rats. J. Pharm. Sci., 61:51-5.
26. Taubeneck, M.W., G.P. Daston, J.M. Rogers and C.L. Keen (1994) Altered maternal zinc metabolism following exposure to diverse developmental toxicants. Reprod. Toxicol., 8:25-40.
27. Taubeneck, M.W., G.P. Daston, J.M. Rogers, M.E. Gershwin, A. Ansari and C.L. Keen (1995) Tumor necrosis factor-alpha alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J. Nutr., 125:908-919.
28. Tomita, I., Y. Nakamura, Y. Yagi and K. Tutikawa (1982) Teratogenicity/ fetotoxicity of DEHP in mice. Environ. Health Perspect., 45:71-75.
29. Tyl, R.W., C.J. Price, M.C. Marr and C.A. Kimmel (1988) Developmental toxicity evaluation of dietary di(2-ethylhexyl)phthalate in Fischer 344 rats and CD-1 mice. Fundam. Appl. Toxicol., 10:395-412.
30. Waalkes, M.P. and J.M. Ward (1989) Induction of hepatic metallothionein in male B6C3F1 mice exposed to hepatic tumor promoters: Effects of phenobarbital, acetaminophen, sodium barbital and di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol., 100:217-226.
31. Ward, J.M., J.M. Peters, C.M. Perella and F.J. Gonzalez (1997) Receptor and non-receptor mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor α-null mice. Toxicol. Pathol., in press.